Technical
Channels
Drug Discovery Drug Development Drug Manufacturing Drug Delivery
Clinical Trials Regulatory and Legal Alliances and Mergers QA/QC and Compliance
Pharmaceutical Processing and Packaging
Ads by Google
Change text size [+] [-]
Lab21 expands international business with launch into India
Tuesday, November 11, 2008
 Email This |  Printer Friendly

Lab21's immunodiagnostic division has entered into a substantial distribution agreement with Inverness Medical India (Spectral Diagnostics Pvt. Ltd) to supply more than 500,000 TPHA kits for the diagnosis of syphilis.

This initial contract will see approximately $1.1 million of reagents supplied into the Indian healthcare market over the next 18 months.



Share this:   Del.icio.us | 
Ask the Expert

Discovery of Cell Water Gate May Lead to New Cancer Drugs

Digital Edition



The R&D outsourcing (CRO) industry in India is currently ahead of that of China’s.
Yes
No
Maybe
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2009 Reed Business Information Asia, a division of Reed Elsevier Inc. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy